← Leaderboards
Richard E Honkanen
University Of South Alabama
$4,984,048
Attributed
$4,984,048
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $359.1K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,984,048 · 5
By mechanism
R01$4,810,715 · 3
R21$148,333 · 1
R03$25,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of South Alabama
Same institution · by research overlap
- Donna L Cioffi$2,732,724
Others in their field
Top investigators on “Carcinogenesis”
- Thomas James Lynch · Fred Hutchinson Cancer Center$52,622,533
- John Anthony Baron · Dartmouth College$42,903,133
- Judith Cheryl Gasson · University Of California Los Angeles$27,647,316
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$27,566,264
- Frank Louis Meyskens · University Of California Irvine$27,314,067
- Paul F Lambert · University Of Wisconsin Madison$25,295,170
Research focus
CarcinogenesisGlucocorticoidsPhosphatase InhibitorOkadaic AcidEnzymesTransfectionMcf7 CellPhosphoprotein PhosphataseDesignNeoplastic CellGeneticHormone Regulation /Control MechanismGene Induction /RepressionProtein KinaseLeadProtein PhosphataseProductionSignal TransductionFamilyComplexMedicalCellsApoptosisPlay
Grant awards (25)
Methods to enable cholesterol catabolism in human monocyte derived macrophages$334,125
R01 · FY2015 · HL · contact PI
Methods to enable cholesterol catabolism in human monocyte derived macrophages$334,125
R01 · FY2014 · HL · contact PI
Methods to enable cholesterol catabolism in human monocyte derived macrophages$324,101
R01 · FY2013 · HL · contact PI
Methods to enable cholesterol catabolism in human monocyte derived macrophages$334,125
R01 · FY2012 · HL · contact PI
Methods to enable cholesterol catabolism in human monocyte derived macrophages$359,125
R01 · FY2011 · HL · contact PI
Development of a HTS-assay for inhibitors of a type 2C protein phosphatase (PPM$148,333
R21 · FY2010 · NS · contact PI
HTP screening for inhibitors of ser/the protein phosphatase 5$25,000
R03 · FY2009 · MH · contact PI
Mechanisms of tumor promotion and carcinogenesis$25,000
R01 · FY2009 · CA · contact PI
Mechanisms of tumor promotion and carcinogenesis$249,183
R01 · FY2008 · CA · contact PI
Mechanisms of tumor promotion and carcinogenesis$249,183
R01 · FY2007 · CA · contact PI
Mechanisms of tumor promotion and carcinogenesis$53,700
R01 · FY2007 · CA · contact PI
Mechanisms of tumor promotion and carcinogenesis$256,624
R01 · FY2006 · CA · contact PI
Mechanisms of tumor promotion and carcinogenesis$52,306
R01 · FY2006 · CA · contact PI
Mechanisms of tumor promotion and carcinogenesis$15,000
R01 · FY2006 · CA · contact PI
Mechanisms of tumor promotion and carcinogenesis$262,800
R01 · FY2005 · CA
Mechanisms of tumor promotion and carcinogenesis$50,953
R01 · FY2005 · CA
Mechanisms of tumor promotion and carcinogenesis$262,800
R01 · FY2004 · CA
Mechanisms of tumor promotion and carcinogenesis$42,339
R01 · FY2004 · CA
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS$252,991
R01 · FY2003 · CA
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS$245,623
R01 · FY2002 · CA
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES$218,511
R01 · FY2002 · HL
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS$238,467
R01 · FY2001 · CA
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES$212,146
R01 · FY2001 · HL
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS$231,522
R01 · FY2000 · CA
CARDIOPROTECTIVE AGENTS IN ISCHEMIC MYOCYTES$205,966
R01 · FY2000 · HL